Entrada Therapeutics, Inc. (TRDA) — DEFA14A Filings
All DEFA14A filings from Entrada Therapeutics, Inc.. Browse 2 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (2)
- DEFA14A Filing — Apr 29, 2026
-
Entrada Therapeutics Files Proxy Statement
— Jun 3, 2025 Risk: low
Entrada Therapeutics, Inc. filed a Definitive Proxy Statement (DEFA14A) on June 3, 2025. This filing is related to the company's proxy materials, likely concern
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX